Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences

Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia). These challenging experiences contribute to hesitancy toward psychedelic-assisted psychotherapy among health care providers and patients. Co-use of 3,4-Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeifman, Richard J., Kettner, Hannes, Pagni, Broc A., Mallard, Austin, Roberts, Daniel E., Erritzoe, David, Ross, Stephen, Carhart-Harris, Robin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444769/
https://www.ncbi.nlm.nih.gov/pubmed/37608057
http://dx.doi.org/10.1038/s41598-023-40856-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444769/
https://www.ncbi.nlm.nih.gov/pubmed/37608057
http://dx.doi.org/10.1038/s41598-023-40856-5

Ejemplares similares